IL157167A0 - Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus - Google Patents

Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus

Info

Publication number: IL157167A0
Authority: IL; Israel
Prior art keywords: reovirus; sensitization; chemotherapeutic agent; neoplastic cells; agent resistant
Prior art date: 2001-02-20

Application number

IL15716702A

Other languages

English (en)

Original Assignee

Oncolytics Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-20

Filing date

2002-02-19

Publication date

2004-02-08

2002-02-19 Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc

2004-02-08 Publication of IL157167A0 publication Critical patent/IL157167A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
- C12N2720/12232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Virology (AREA)
Diabetes (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Mycology (AREA)
Microbiology (AREA)
Oncology (AREA)
Endocrinology (AREA)
Inorganic Chemistry (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL15716702A 2001-02-20 2002-02-19 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus IL157167A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US27036301P	2001-02-20	2001-02-20
PCT/CA2002/000201 WO2002066040A2 (en)	2001-02-20	2002-02-19	Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus

Publications (1)

Publication Number	Publication Date
IL157167A0 true IL157167A0 (en)	2004-02-08

Family

ID=23031034

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL15716702A IL157167A0 (en)	2001-02-20	2002-02-19	Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
IL157167A IL157167A (en)	2001-02-20	2003-07-30	Reovirus medicinal product and antitumor for the treatment or prevention of cancer and commercial packaging containing the reovirus and antitumor

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL157167A IL157167A (en)	2001-02-20	2003-07-30	Reovirus medicinal product and antitumor for the treatment or prevention of cancer and commercial packaging containing the reovirus and antitumor

Country Status (15)

Country	Link
US (5)	US7264798B2 (es)
EP (2)	EP2314301A3 (es)
JP (3)	JP4951194B2 (es)
AR (1)	AR035227A1 (es)
AT (1)	ATE516807T1 (es)
AU (2)	AU2002234453B2 (es)
BR (1)	BR0207691A (es)
CA (1)	CA2437468C (es)
DK (1)	DK1361884T3 (es)
ES (1)	ES2367768T3 (es)
IL (2)	IL157167A0 (es)
MX (1)	MXPA03007486A (es)
NZ (2)	NZ527399A (es)
WO (1)	WO2002066040A2 (es)
ZA (1)	ZA200305875B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6110461A (en) *	1997-08-13	2000-08-29	Oncolytics Biotech Inc.	Reovirus for the treatment of neoplasia
US6136307A (en)	1997-08-13	2000-10-24	Oncolytics Biotech Inc.	Reovirus for the treatment of cellular proliferative disorders
AR035227A1 (es)	2001-02-20	2004-05-05	Oncolytics Biotech Inc	Uso de un agente quimioterapeutico para la manufactura de un medicamento para la sensibilizacion de celulas neoplasicas resistentes a agentes quimioterapeuticos con reovirus
WO2003094939A1 (en)	2002-05-10	2003-11-20	Oncolytics Biotech Inc.	Sensitization of neoplastic cells to radiation therapy with oncolytic viruses
WO2004096126A2 (en) *	2003-04-25	2004-11-11	Wellstat Biologics Corporation	Treating hepatocellular carcinomas using therapeutic viruses
EP1644492B1 (en)	2003-06-18	2009-01-07	Genelux Corporation	Modified recombinant vaccinia viruses, uses thereof
CA2562904C (en) *	2004-04-27	2013-07-02	Wellstat Biologics Corporation	Cancer treatment using viruses and camptothecins
WO2005112966A1 (en) *	2004-05-21	2005-12-01	Orison Biotechnology Inc.	Combined therapy with a herbal extract and a reovirus for killing neoplastic cells in a subject
KR20080039344A (ko) *	2005-07-14	2008-05-07	웰스테트 바이올로직스 코포레이션	바이러스, 플루오로피리미딘 및 캄토테신을 이용한 암치료방법
US10668119B2 (en)	2005-08-01	2020-06-02	Virocure, Inc.	Attenuated reovirus
WO2007099401A2 (en) *	2005-08-01	2007-09-07	University Technologies International, Inc.	Oncolytic attenuated reoviruses for treatment of proliferative disorders
ES2335308T3 (es) *	2005-11-24	2010-03-24	AICURIS GMBH & CO. KG	Parapoxvirus en combinacion con agentes quimioterapeuticos clasicos como bioquimoteparia para el tratamiento del cancer.
WO2008100292A2 (en)	2006-10-16	2008-08-21	Genelux Corporation	Modified vaccinia virus strains for use in diagnostic and therapeutic methods
US8168661B2 (en) *	2006-11-06	2012-05-01	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US8168662B1 (en)	2006-11-06	2012-05-01	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US8173686B2 (en)	2006-11-06	2012-05-08	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US8178564B2 (en) *	2006-11-06	2012-05-15	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) *	2009-08-05	2011-02-10	Poniard Pharmaceuticals, Inc.	Stabilized picoplatin oral dosage form
US10369171B2 (en)	2007-03-13	2019-08-06	Virocure, Inc.	Attenuated reoviruses for selection of cell populations
WO2008150496A2 (en) *	2007-05-31	2008-12-11	Genelux Corporation	Assay for sensitivity to chemotherapeutic agents
US20100260832A1 (en) *	2007-06-27	2010-10-14	Poniard Pharmaceuticals, Inc.	Combination therapy for ovarian cancer
TW200916094A (en) *	2007-06-27	2009-04-16	Poniard Pharmaceuticals Inc	Stabilized picoplatin dosage form
JP2010533718A (ja) *	2007-07-18	2010-10-28	ジェネラックス・コーポレイション	腫瘍溶解性ウイルス治療に付随する副作用の処置もしくは改善用医薬の製造における化学治療剤の使用
AU2008316276A1 (en) *	2007-10-22	2009-04-30	Oncolytics Biotech Inc.	Treatment regime for proliferative disorders
CN102006875A (zh) *	2008-02-08	2011-04-06	帕纳德制药公司	吡铂和贝伐单抗治疗结直肠癌的用途
EP2300023A2 (en) *	2008-05-16	2011-03-30	Genelux Corporation	Microorganisms for preventing and treating neoplasms accompanying cellular therapy
KR101585702B1 (ko) *	2008-05-22	2016-01-15	제일약품주식회사	종양파괴 바이러스 요법에 대한 과다증식성 세포의 종양 억제인자-기초된 민감성
EP2296679A4 (en) *	2008-05-27	2012-03-21	Oncolytics Biotech Inc	SUPPRESSION OF PRODUCTION OF PRO-INFLAMMATORY CYTOKINES DURING ONCOLYTIC REOVIRUS THERAPY
EP2296678A4 (en) *	2008-05-27	2012-03-21	Oncolytics Biotech Inc	MODULATION OF INTERSTITIAL PRESSURE AND ONCOLYTIC VIRUS RELIEF AND DISTRIBUTION
WO2013163724A1 (en) *	2012-04-30	2013-11-07	Oncolytics Biotech Inc.	Protecting modified viruses from neutralizing antibodies using the reovirus sigma 1 protein
MX389560B (es)	2014-10-24	2025-03-20	Calidi Biotherapeutics Nevada Inc	Enfoque de inmunoterapias de combinación para el tratamiento del cancer.
CN104881181B (zh) *	2015-05-27	2019-07-26	联想(北京)有限公司	显示方法及电子设备
CA3177862A1 (en)	2018-11-06	2020-05-14	Calidi Biotherapeutics, Inc.	Enhanced systems for cell-mediated oncolytic viral therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0931830B1 (en)	1993-02-16	2001-03-07	Onyx Pharmaceuticals, Inc.	Cytopathic viruses for therapy and phophylaxis of neoplasia
WO1994025627A1 (en)	1993-04-30	1994-11-10	Lorence Robert M	Methods of treating and detecting cancer using viruses
US5776743A (en)	1994-09-06	1998-07-07	La Jolla Cancer Research Foundation	Method of sensitizing tumor cells with adenovirus E1A
US6136307A (en)	1997-08-13	2000-10-24	Oncolytics Biotech Inc.	Reovirus for the treatment of cellular proliferative disorders
US6565831B1 (en) *	1999-02-24	2003-05-20	Oncolytics Biotech Inc.	Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
US6110461A (en)	1997-08-13	2000-08-29	Oncolytics Biotech Inc.	Reovirus for the treatment of neoplasia
NZ503664A (en)	1997-10-09	2002-08-28	Pro Virus Inc	A method for purifying an RNA virus comprising generating a clonal virus and purifying the clonal virus by ultracentrifugation without pelleting
US6428968B1 (en) *	1999-03-15	2002-08-06	The Trustees Of The University Of Pennsylvania	Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject
WO2001035970A1 (en) *	1999-11-12	2001-05-25	Oncolytics Biotech Inc.	Viruses for the treatment of cellular proliferative disorders
AR035227A1 (es) *	2001-02-20	2004-05-05	Oncolytics Biotech Inc	Uso de un agente quimioterapeutico para la manufactura de un medicamento para la sensibilizacion de celulas neoplasicas resistentes a agentes quimioterapeuticos con reovirus
US7163678B2 (en) *	2002-11-07	2007-01-16	Oncolytics Biotech Inc.	Reovirus for the treatment of ral-mediated cellular proliferative disorders

2002
- 2002-02-12 AR ARP020100466A patent/AR035227A1/es unknown
- 2002-02-15 US US10/076,074 patent/US7264798B2/en not_active Expired - Lifetime
- 2002-02-19 WO PCT/CA2002/000201 patent/WO2002066040A2/en not_active Ceased
- 2002-02-19 EP EP10013901A patent/EP2314301A3/en not_active Withdrawn
- 2002-02-19 DK DK02701122.0T patent/DK1361884T3/da active
- 2002-02-19 AU AU2002234453A patent/AU2002234453B2/en not_active Expired
- 2002-02-19 JP JP2002565598A patent/JP4951194B2/ja not_active Expired - Lifetime
- 2002-02-19 NZ NZ527399A patent/NZ527399A/en unknown
- 2002-02-19 EP EP02701122A patent/EP1361884B1/en not_active Expired - Lifetime
- 2002-02-19 ES ES02701122T patent/ES2367768T3/es not_active Expired - Lifetime
- 2002-02-19 IL IL15716702A patent/IL157167A0/xx unknown
- 2002-02-19 NZ NZ537709A patent/NZ537709A/en unknown
- 2002-02-19 CA CA002437468A patent/CA2437468C/en not_active Expired - Lifetime
- 2002-02-19 AT AT02701122T patent/ATE516807T1/de not_active IP Right Cessation
- 2002-02-19 BR BR0207691-8A patent/BR0207691A/pt not_active IP Right Cessation
- 2002-02-19 MX MXPA03007486A patent/MXPA03007486A/es active IP Right Grant
2003
- 2003-07-30 ZA ZA200305875A patent/ZA200305875B/en unknown
- 2003-07-30 IL IL157167A patent/IL157167A/en active IP Right Grant
2007
- 2007-05-31 US US11/809,293 patent/US7608257B2/en not_active Expired - Lifetime
- 2007-08-16 AU AU2007207860A patent/AU2007207860B2/en not_active Expired
2008
- 2008-02-18 JP JP2008036723A patent/JP2008120837A/ja not_active Withdrawn
2009
- 2009-09-08 US US12/555,453 patent/US7964187B2/en not_active Expired - Fee Related
2011
- 2011-05-17 US US13/109,631 patent/US20110243890A1/en not_active Abandoned
2012
- 2012-01-13 JP JP2012005027A patent/JP2012072192A/ja active Pending
- 2012-09-24 US US13/625,259 patent/US8658158B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
AR035227A1 (es)	2004-05-05
CA2437468C (en)	2007-06-19
US7608257B2 (en)	2009-10-27
EP2314301A2 (en)	2011-04-27
ZA200305875B (en)	2004-07-30
US20110243890A1 (en)	2011-10-06
DK1361884T3 (da)	2011-10-03
WO2002066040A2 (en)	2002-08-29
WO2002066040A8 (en)	2003-03-20
HK1060520A1 (en)	2004-08-13
WO2002066040A3 (en)	2003-05-30
US20100021432A1 (en)	2010-01-28
ATE516807T1 (de)	2011-08-15
US7964187B2 (en)	2011-06-21
JP4951194B2 (ja)	2012-06-13
JP2008120837A (ja)	2008-05-29
EP1361884B1 (en)	2011-07-20
BR0207691A (pt)	2006-01-31
AU2007207860A1 (en)	2007-09-06
ES2367768T3 (es)	2011-11-08
NZ527399A (en)	2005-09-30
AU2007207860B2 (en)	2008-10-23
US7264798B2 (en)	2007-09-04
JP2004517966A (ja)	2004-06-17
JP2012072192A (ja)	2012-04-12
IL157167A (en)	2014-05-28
EP2314301A3 (en)	2011-08-17
AU2002234453B2 (en)	2007-05-17
US20080031851A1 (en)	2008-02-07
US20130017172A1 (en)	2013-01-17
US20020168344A1 (en)	2002-11-14
NZ537709A (en)	2006-11-30
US8658158B2 (en)	2014-02-25
EP1361884A2 (en)	2003-11-19
MXPA03007486A (es)	2003-12-08
CA2437468A1 (en)	2002-08-29

Publication	Publication Date	Title
IL157167A0 (en)	2004-02-08	Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
DK1381339T3 (da)	2009-08-24	Tampon med spiralformede riller
AU144209S (en)	2001-06-19	Pocket lamp
AU2003275140A8 (en)	2004-04-08	Theree-dimensional construct for the design and fabrication of physiological fluidic networks
GB0130688D0 (en)	2002-02-06	Reflectors
DE60007051D1 (de)	2004-01-22	Biegsame Röhre und dessen Herstellung
SG108876A1 (en)	2005-02-28	Multiple hydroprocessing reactors with intermediate flash zones
IL160772A0 (en)	2004-08-31	Pancreatic smal cells and uses thereof
IL174121A0 (en)	2006-08-01	Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
AU2002301545A1 (en)	2003-06-12	Multiple hydroprocessing reactors with intermediate flash zones
GB0127033D0 (en)	2002-01-02	Stent manufacture
HUP0600238A3 (en)	2009-12-28	Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
GB2374292B (en)	2003-04-23	Portable infant carrier
GB0016943D0 (en)	2000-08-30	Drills and their manufacture
GB0102717D0 (en)	2001-03-21	Cells and uses therefor
DE60238285D1 (de)	2010-12-23	Alkalische Speicherbatterie und dessen Herstellungsverfahren
DE60030708D1 (de)	2006-10-26	Beschichtete Hartmetallkörper
GB0014221D0 (en)	2000-08-02	Discharge bulb
GB0000699D0 (en)	2000-03-08	Gas discharge lamp
GB0126000D0 (en)	2001-12-19	Use of 4ñ Phorbol
TW527019U (en)	2003-04-01	Improved structure of cubic cell
TW576493U (en)	2004-02-11	Improved lamp body structure
GB0101943D0 (en)	2001-03-07	Ultra violet reflector
TWI319005B (en)	2010-01-01	Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
TW450340U (en)	2001-08-11	Water lamp structure with inner and outer tubes